Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Dec;43(4):424-32.
doi: 10.1016/j.jsat.2012.08.007. Epub 2012 Oct 2.

Concurrent group treatment for hepatitis C: implementation and outcomes in a methadone maintenance treatment program

Melissa R Stein  1 , Irene J Soloway, Karen S Jefferson, Robert J Roose, Julia H Arnsten, Alain H Litwin
Affiliations

Concurrent group treatment for hepatitis C: implementation and outcomes in a methadone maintenance treatment program

Melissa R Stein et al. J Subst Abuse Treat. 2012 Dec.

Abstract

Chronic hepatitis C virus (HCV) infection is highly prevalent among current and former drug users. However, the minority of patients enrolled in drug treatment programs have initiated HCV treatment. New models are needed to overcome barriers to care. In this retrospective study, we describe the implementation and outcomes of 42 patients treated in a concurrent group treatment (CGT) program. Patients participated in weekly provider-led group treatment sessions which included review of side effects; discussion of adherence and side effect management; administration of interferon injections; brief physical examination; and ended with brief meditation. Of the first 27 patients who initiated CGT, 42% achieved a sustained viral response. In addition, 87% (13/15) of genotype-1 infected patients treated with direct acting antiviral agent achieved an undetectable viral load at 24 weeks. The CGT model may be effective in overcoming barriers to treatment and improving adherence and outcomes among patients enrolled in drug treatment programs.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Figure 1
Figure 1
Figure 2
Figure 2
Figure 3
Figure 3
See this image and copyright information in PMC

References

    1. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States 1999 through 2002. Annals of Internal Medicine. 2006;138:187–190. - PubMed
    1. Backmund M, Meyer K, Edlin B. Infrequent reinfection after successful treatment for hepatitis C virus infection in injection drug users. Clin Infect Dis. 2004;39(10):1540–1543. - PMC - PubMed
    1. Backus LI, Boothroyd DB, Phillips BR, Mole LA. Predictors of response of U.S. veterans to treatment for the hepatitis C virus. Hepatology. 2007;46:37–47. - PubMed
    1. Bini EJ, Brau N, Currie S, et al. Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infection. Am J Gastroenterol. 2005;100:1772–1779. - PubMed
    1. Bronson D, Maxwell R. Shared medical appointments: increasing patient access without increasing physician hours. Cleveland Clinic Journal of Medicine. 2008;71:369–377. - PubMed

Publication types

MeSH terms